Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) designs, develops, and markets exoskeleton products that augment human strength, endurance, and mobility. Its exoskeleton technology serves multiple markets and can be utilized by able-bodied persons and persons with physical disabilities or impairments. Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) Market Cap:...
Melanoma, a form of skin cancer, accounts for about 1% of skin cancers but is responsible for over 7,650 deaths every year as per an estimate by the American Cancer Society, these numbers are steadily rising over the years with approximately 99,780 new melanomas diagnosis being made each year. The...
Insider selling cannot be the sole indicator for investing in a stock, but it would be wise to make a note of the buying and selling activities to gauge a company’s prospects or the lack thereof. While insiders buying or selling the Company’s stock could...
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is focused on developing innovative small molecule drugs that target hematologic disorders, cancer and rare immune diseases. The Company announced positive topline results from a phase 2 evaluation of fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, intended for the...
Nerve Stimulation is a process that involves the use of electrical stimulation technology to treat chronic pain and is categorized into Spinal Cord Stimulation and Peripheral Nerve Stimulation. These are further classified into deep brain stimulators, vagus nerve stimulators, spinal cord, sacral nerve and gastric...
INmune Bio (NASDAQ: INMB), a clinical-stage Company focussed on creating novel immunotherapies for the treatment of hematologic malignancies and solid tumors, announced the award of a grant of $500,000 by the ALS Association, an association not only providing care and assistance to those suffering from...
Cure Pharmaceutical (OTCQB: CURR), a Company leveraging its proprietary drug dosage forms and delivery systems to create innovative therapeutics in collaboration with leading biotech and pharmaceutical companies, announced the signing of an exclusive licensing agreement with ReLeaf Europe, a leading European Medicinal Cannabis Company. ReLeaf...
Huntington’s disease is a progressive degeneration of the neurons in the brain resulting in loss of cognition, motor ability, uncontrolled movements and emotional distress. The disease can be categorized into adult onset, which manifests in the form of depression, irritability, lack of coordination and poor...
BrainStorm Cell Therapeutics (NASDAQ: BCLI), a Company focussed on developing autologous cellular therapies for neurodegenerative diseases, has been awarded the Buzz of Bio 2020 in the public therapeutic biotech category. The award recognises the efforts of Brainstorm in the field of neurodegenerative diseases, including progressive...
Gout is a form of inflammatory Arthritis caused by high levels of uric acid in the blood, and is characterised by the formation of needle-like crystals in the joints that cause pain, tenderness and swelling. The disease manifests in four stages namely Asymptomatic hyperuricemia in...
